Smoking is associated with lung inflammation and a protease-antiprotease imbalance. We previously reported that cigarette smoke extract (CSE) stimulates human lung fibroblasts to release chemotactic cytokines. We hypothesized that serine protease inhibitors might modulate lung fibroblast release of chemotactic cytokines in response to CSE. To test this hypothesis, serine protease inhibitors (FK706, α1-antitrypsin, methoxysuccinyl-Ala-Ala-Pro-Val chloromethyl ketone; SPCK, or Nα-p-tosyl-L-lysine chloromethyl ketone; TLCK) were evaluated for their capacity to attenuate the release of neutrophil chemotactic activity (NCA) and monocyte chemotactic activity (MCA) from human fetal lung fibroblasts (HFL-1) by the blind-well chemotactic chamber.
Introduction
Cigarette smoking is the major factor leading to the development of chronic bronchitis, emphysema, and chronic obstructive pulmonary disease (COPD) (1) . Current concepts suggest the pathogenesis of emphysema is an imbalance between proteases and antiproteases in the lung (2) . An infiltration of inflammatory cells including neutrophils, monocytes, and macrophages, play a critical role in tipping the protease-antiprotease balance toward protease excess. Increased numbers of neutrophils and monocytes activated by cigarette smoke produce large amounts of proteases and oxidants that inactivate anti-proteases resulting in lung destruction (3) . Protease inhibitors may protect the lung from the detrimental destruction by proteases. However, antiproteases may also modulate neutrophil migration further reducing lung inflammation and destruction (4).
The lung fibroblast plays an important role in maintenance of the extracellular matrix and in tissue repair after injury. Synthesis of the extracellular matrix serves an important structural function by providing a frame network for organ integrity. In addition to this traditionally accepted function, there is evidence suggesting that fibroblasts may modulate inflammation by producing chemokines such as interleukin (IL)-8, monocyte chemoattractant protein (MCP)-1, granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage (GM)-CSF in response to cigarette smoke extract (CSE) (5) .
Moreover, fibroblasts secrete a variety of proteases including plasmin (6), fibroblast-activation protein (7), tissue-type plasminogen activator (8) , urokinase-type plasminogen activator (9) , and a calcium-dependent serine protease (10) . Therefore, the fibroblast, because of its anatomical location, production, and protease secretion, is at a pivotal position to participate in and direct communications between interstitial and vascular events in pulmonary inflammation and fibrosis.
The effect of protease inhibitors on cigarette smoke-inflammation has not been extensively studied. We hypothesized that anti-proteases might reduce the cigarette smoke-induced release of chemotactic factors from lung fibroblasts. The purpose of this study was to test this hypothesis by studying the effects of protease inhibitors on neutrophil and monocyte chemotactic activity released a human lung fibroblast cell line (HFL-1) exposed to cigarette smoke extract. In addition, we determined whether FK706, a synthetic serine protease inhibitor, might attenuate the production of inflammatory chemokines and chemokine mRNA expression, and since current concepts suggest that these chemokines are regulated at least in part by NF-κB (11), we also evaluated for NF-κB activation.
Materials and Methods

Cell cultures.
Human fetal lung fibroblasts (HFL-1, lung, diploid, human, passage 14) were purchased from the American Type Tissue Culture Collection (Rockville, MD). The HFL-1 cells were cultured according previously described methods in Ham's F-12 medium with 10% heat-inactivated fetal bovine serum (5). After 2-4 days in culture, the cells had reached confluence and were then used for experiments.
Preparation of cigarette smoke extract.
Cigarette smoke extract was prepared with a modification of the method of Laurent et al. (12) . Briefly, two cigarettes (CAMEL, R.J. Reynolds Tobacco CO, Winston-Salem, NC) without filters were combusted with a modified syringe-driven apparatus. The smoke was bubbled through 50 ml of Hanks' balanced salt solution (HBSS, GIBCO BRL). The resulting suspension was adjusted to pH 7.4 and filtered through a 0.2-µm filter (Nalge Nunc International, Rochester, NY) to remove bacteria and large particles. CSE was stored at -80° C until used. Smoke extract prepared by this method contained less than 10 ng/ml of bacterial endotoxin in 10 % smoke extract solution, as determined by the Limulus test using Endotoxin Test Kit (Seikagaku Kogyo, Tokyo, Japan) (13) .
Protease inhibitors and stimulants.
FK706 (C26H32F3N4NaO7, Fujisawa Pharmaceutical Co., Osaka, Japan) was used as a serine protease inhibitor (14) . After the cells had reached confluence, the culture medium was removed, the cells washed twice with serum-free Ham's F-12 medium, and the cells incubated in the presence or absence of CSE (0, 0.5, 1, 5, and 10%) for 72 h at 37°C in a humidified 5% CO 2 atmosphere. In some experiments, HFL-1 cells were pretreated with several concentrations of the serine protease inhibitors, FK706 (5, 10, and 50 µg/ml), showing that neutrophil elastase-induced lung hemorrhage of mice was significantly inhibited by intratracheal treatment with FK706 at the dose from 1-100 µg (14) . In addition, the concentrations of other protease inhibitors were decided in accordance with previous studies (4). CSE was not cytotoxic as assessed by cell shape, cell detachment, and trypan blue exclusion after 72 h at 10% concentration (no deformity of cell shape, no detachment from culture dish and >98% viability). The supernatant fluids were harvested and stored at -80°C until assayed. At least six HFL-1 fibroblast culture supernatant fluids were harvested for each experimental condition. Elmer model 480 thermal cycler using 94° C for 2 minutes and 20 cycles consisting of 94° C for 45 seconds, primer annealing at 55° C for 45 seconds, primer extension at 72° C for 45 seconds, followed by 72° C for an additional 7 minutes. β-actin was used as a "housekeeping gene" with PCR. The DNA was subjected to agarose gel and the intensity of the bands quantified by densitometry. The results were expressed as the ratio of intensity to the β-actin.
Measurement of NF-κB activation
The activation of NF-κB was analyzed by commercially available NF-κB p65 transcription factor assay kits (Active Motif, Carlsbad, CA) according to the manufacturer's instructions in duplicate. HFL-1 cells were pretreated with FK706 and CSE for 1 hour and whole-cell extract was prepared as previously described (17) . The protein concentration of the cell extract was determined by using a modified Bradford-based assay (18) , and the amount of protein of cell extract was adjusted 10 µg per well. NF-κB activation was evaluated with reading optical density at 450 nm. The detection limit by this method was 0.5 µg cell extract per well.
Statistical analysis.
Data was analyzed by one-way analysis of variance (ANOVA) with Fisher's protected least significant difference (Fisher's PLSD). In all cases, a p value of <0.05 was considered significant. The data are expressed as mean + SD. However, a limitation of these studies was that they were done in vitro with a human fibroblast cell line. The effects of protease inhibitors on primary cultures of human airway fibroblasts and demonstrating this phenomenon in vivo are important issues for future research.
Results
Release
FK706 is a water-soluble, chrolmethyl ketone derivative that inhibits serine proteases (14) . The Ki value for human neutrophil elastase is 4.2 nM. This compound inhibits human neutrophil elastase activity and porcine pancreatic elastase activity with respective IC 50 values of 83 nM and 100 nM. FK706 acts against the elastase-induced lung hemorrhage and elastase-induced skin edema in animal models (14) . FK706 
